Fundz

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-Viral Drug Delivery Platform

PRIVATEMay 12, 2022

Round Type

Venture

MilanBiotechnologyHealth Care

Description

MILAN, ITALY / May 12, 2022 / Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today a €3.5 million seed investment in NanoPhoria, a pre-clinical stage biotech company that is developing a versatile, non-viral drug delivery platform based on inorganic nanoparticles.

Quick answer

NanoPhoria raised an undisclosed amount in a funding round, dated May 12, 2022. NanoPhoria is based in Milan, Lombardy, Italy.

How much did NanoPhoria raise?
NanoPhoria raised an undisclosed amount in a funding round on May 12, 2022.
What does NanoPhoria do?
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics.
Where is NanoPhoria based and how big is it?
NanoPhoria is based in Milan, Lombardy, Italy. Fundz records about 7 employees.
Who are the decision-makers at NanoPhoria?
Fundz holds 2 contacts at NanoPhoria. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as NanoPhoria that raised within 45 days of this round, from Fundz verified event records.

  • CHARM Therapeutics raised $37M on June 24, 2022.
  • Epoch Biodesign raised an undisclosed amount (Seed) on June 22, 2022.
  • My Ome raised $23M (Series B) on June 21, 2022.
  • BioLumic raised $14M (Series B) on June 21, 2022.
  • Astaria Global raised $8M (Seed) on June 20, 2022.
  • Akero Therapeutics raised an undisclosed amount (Funding Round) on June 16, 2022.

Who to call at NanoPhoria, and when

A new round usually means NanoPhoria is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NanoPhoria raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NanoPhoria, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NanoPhoria. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NanoPhoria

Location

Milan, Lombardy, Italy

About

NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics. The Company is devoted to the clinical development of an innovative proprietary platform for the tissue-directed delivery of therapeutic peptides and RNAs. The core vehicle is an inorganic calcium-phosphate nanoparticle which represents a versatile, biomimetic nano-carrier that can be loaded or surface decorated with biologics and can be formulated for inhalation or for other administration routes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NanoPhoria raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for NanoPhoria's next move

See what Strategic adds

NanoPhoria raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.